{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,15]],"date-time":"2026-01-15T12:23:35Z","timestamp":1768479815298,"version":"3.49.0"},"reference-count":4,"publisher":"Massachusetts Medical Society","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["N Engl J Med"],"published-print":{"date-parts":[[2018,7,5]]},"DOI":"10.1056\/nejmp1804059","type":"journal-article","created":{"date-parts":[[2018,7,4]],"date-time":"2018-07-04T21:01:16Z","timestamp":1530738076000},"page":"4-6","source":"Crossref","is-referenced-by-count":36,"title":["Moving Addiction Care to the Mainstream \u2014 Improving the Quality of Buprenorphine Treatment"],"prefix":"10.1056","volume":"379","author":[{"given":"Brendan","family":"Saloner","sequence":"first","affiliation":[{"name":"From the Departments of Health Policy and Management (B.S.) and Epidemiology (G.C.A.), Johns Hopkins Bloomberg School of Public Health, the Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine (K.B.S.), the Center for Drug Safety and Effectiveness, Johns Hopkins University (G.C.A.), and the Division of General Internal Medicine, Department of Medicine, Johns Hopkins Medicine (G.C.A.) \u2014 all in Baltimore."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kenneth B.","family":"Stoller","sequence":"additional","affiliation":[{"name":"From the Departments of Health Policy and Management (B.S.) and Epidemiology (G.C.A.), Johns Hopkins Bloomberg School of Public Health, the Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine (K.B.S.), the Center for Drug Safety and Effectiveness, Johns Hopkins University (G.C.A.), and the Division of General Internal Medicine, Department of Medicine, Johns Hopkins Medicine (G.C.A.) \u2014 all in Baltimore."}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"G. Caleb","family":"Alexander","sequence":"additional","affiliation":[{"name":"From the Departments of Health Policy and Management (B.S.) and Epidemiology (G.C.A.), Johns Hopkins Bloomberg School of Public Health, the Department of Psychiatry and Behavioral Sciences, Johns Hopkins University School of Medicine (K.B.S.), the Center for Drug Safety and Effectiveness, Johns Hopkins University (G.C.A.), and the Division of General Internal Medicine, Department of Medicine, Johns Hopkins Medicine (G.C.A.) \u2014 all in Baltimore."}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"150","reference":[{"key":"r1","volume-title":"Medications to treat opioid use disorder","year":"2018"},{"key":"r2","doi-asserted-by":"publisher","DOI":"10.1097\/MLR.0000000000000727"},{"key":"r4","doi-asserted-by":"publisher","DOI":"10.1016\/j.drugalcdep.2017.03.033"},{"key":"r5","doi-asserted-by":"publisher","DOI":"10.1001\/jamainternmed.2017.0518"}],"container-title":["New England Journal of Medicine"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/www.nejm.org\/doi\/pdf\/10.1056\/NEJMp1804059","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,12,10]],"date-time":"2018-12-10T10:35:33Z","timestamp":1544438133000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.nejm.org\/doi\/10.1056\/NEJMp1804059"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,7,5]]},"references-count":4,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,7,5]]}},"alternative-id":["10.1056\/NEJMp1804059"],"URL":"https:\/\/doi.org\/10.1056\/nejmp1804059","relation":{},"ISSN":["0028-4793","1533-4406"],"issn-type":[{"value":"0028-4793","type":"print"},{"value":"1533-4406","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,7,5]]}}}